-
公开(公告)号:DE60221041T2
公开(公告)日:2008-04-10
申请号:DE60221041
申请日:2002-12-20
Applicant: SERVIER LAB
Inventor: CORDI ALEX , DESOS PATRICE , LESTAGE PIERRE
IPC: C07D279/02 , A61K31/5415 , A61K31/549 , A61P9/10 , A61P25/08 , A61P25/14 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07B61/00 , C07D285/24
Abstract: Benzothia(dia)zine derivatives (I), their isomers and salts are new. Benzothia(dia)zine derivatives (I), their isomers and salts are new; R1 = OH or RCOO-; R2 = H, halogen, OH or R'COO-; R, R' = 1-6C alkyl or 2-6C alkenyl (both optionally substituted by aryl), 1-6C perhaloalkyl, 3-7C cycloalkyl, adamantyl, aryl, or heteroaryl; R3 = H, 1-6C alkyl, or 3-7C cycloalkyl; A = CR4R5 or NR4; R4 = H or 1-6C alkyl; R5 = H or halogen Provided that: (1) when R1 is RCOO- it is in position 5; (2) aryl groups are mono or bicyclic and may be substituted by alkyl, alkoxy, perhaloalkyl, perhaloalkoxy, OH, CN, alkyl, mono- or dialkylamino, aminosulfonyl, mono or dialkylaminosulfonyl, or optionally substituted phenyl; and (3) heteroaryl groups may have up to three heteroatoms (O, N, S), may be mono or bicyclic and may be substituted as described for aryl groups. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:ECSP088127A
公开(公告)日:2008-02-20
申请号:ECSP088127
申请日:2008-01-21
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , GUILLONNEAU CLAUDE , CHARTON YVES , LOCKHART BRIAN , LESTAGE PIERRE
IPC: A61K31/44 , A61P25/00 , C07D213/74
Abstract: Compuesto de Fórmula I en la que:n representa un número entero comprendido entre 1 y 6 inclusive,R1 y R2 representan un átomo de hidrógeno, un grupo alquilo (C1-C6) o arilalquilo (C1-C6), R3 y R4 representan un átomo de hidrógeno, un grupo alquilo (C1-C6)R5 y R6 representan un átomo de hidrógeno, un grupo alquilo (C1-C6) halógeno, hidroxi, alcoxi, (C1-C6), ciano, nitro, acilo (C2-C6), alcoxicarbonilo (C1-C6), trihalógenoalquilo (C1-C6) trihalógenoalcoxi (C1-C6) o amino sustituidos opcionalmente,R7 representa un átomo de hidrógeno, un grupo alquilo (C1-C6) o arialquilo.Medicamentos
-
公开(公告)号:DE602005003907D1
公开(公告)日:2008-01-31
申请号:DE602005003907
申请日:2005-11-02
Applicant: SERVIER LAB
Inventor: DESOS PATRICE , CORDI ALEXIS , LESTAGE PIERRE
IPC: A61K31/5415 , A61P25/00 , C07D285/24
Abstract: Benzothiadiazine compounds (I) and their enantiomers, diastereoisomers and addition salts with an acid or base are new. Benzothiadiazine compounds of formula (I) and their enantiomers, diastereoisomers and addition salts with an acid or base are new. R 11-6C alkyl substituted by halo(s); R 2H, halo or OH; R 3aryl (optionally substituted by 1-6C alkyl(s)), 1-6C polyhaloalkyl, halo, 1-6C alkoxy-carbonyl, 1-6C alkylthio, carboxy, 1-6C acyl, 1-6C (polyhalo)alkoxy, OH, CN, nitro, amidino (optionally substituted by 1 or 2 1-6C alkyl, OH, 1-6C alkoxy or -O-(C(=O))-R 12), amino (optionally substituted by 1 or 2 1-6C alkyl), aminocarbonyl (optionally substituted by 1 or 2 1-6C alkyl), benzyloxy, 1-6C alkylsulfonylamino (optionally substituted on the N by 1-6C alkyl), trifluoromethylsulfonylamino, heterocyclic or 1-6C alkyl (substituted by halo, 1-6C alkyl, NR 4R 5, S(O) nR 6, OR 7, amidino (optionally substituted by 1 or 2 1-6C alkyl, OH, 1-6C alkoxy or -O-(C=O)-R 12) and/or heterocyclic); R 4H, 1-6C alkyl, S(O) pR 8, COR 9 or P(O)(OR 10)(OR 11); and R 5H or 1-6C alkyl; or NR 4R 5heterocyclic; R 6, R 8-R 12H, 1-6C alkyl (optionally substituted by halo(s)), aryl-(1-6C alkyl) or aryl; R 71-6C alkyl or 1-6C acyl; and n, p : 0-2. [Image] ACTIVITY : Nootropic; Tranquilizer; Antidepressant; Neuroprotective; Cerebroprotective; Anticonvulsant; Neuroleptic; Vasotropic. MECHANISM OF ACTION : Alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) modulator. The ability of (I) to modulate AMPA was assessed using rats. The results showed that N-(4-{[4-(2-bromoethyl)-1,1-dioxido-3,4-dihydro-2H-1,2,4-benzothiadiazin-7-yl]oxy}benzyl)methanesulfonamide exhibited an EC2X value of 0.04 mu M.
-
公开(公告)号:AU2002364673B2
公开(公告)日:2007-11-22
申请号:AU2002364673
申请日:2002-12-20
Applicant: SERVIER LAB
Inventor: DESOS PATRICE , LESTAGE PIERRE , CORDI ALEX
IPC: C07D285/24 , A61K31/549 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , C07D279/02 , C07D513/04
Abstract: Benzothiazine and benzothiadiazine derivatives (I) their isomers and salts are new. Benzothiazine and benzothiadiazine derivatives (I) their isomers and salts are new; R1 = aryl or heteroaryl; R2 = H, halogen, or OH; X = O or S; Y = O, S, or NR; R = H or 1-6C alkyl; A = CR4R5, NR4 or it may be N and form a with the adjacent group CHR3 a group of formula (i); m = 1-3; R3 = H, 1-6C alkyl or 3-7C cycloalkyl; R4 = H or 1-6C alkyl; R5 = H or halogen. Provided that: (1) aryl groups are mono or bicyclic and may be substituted by alkyl, alkoxy, perhaloalkyl, perhaloalkoxy, OH, CN, alkyl, mono- or dialkylamino, aminosulfonyl, mono or dialkylaminosulfonyl, or optionally substituted phenyl; and (2) heteroaryl groups may have up to three heteroatoms (O, N, S), may be mono or bicyclic and may be substituted as described for aryl groups. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:AR055589A1
公开(公告)日:2007-08-29
申请号:ARP060103248
申请日:2006-07-27
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , GUILLONNEAU CLAUDE , CHARTON YVES , LOCKHART BRIAN , LESTAGE PIERRE
Abstract: Composiciones farmacéuticas que los contienen, método de preparacion y usos para tratar neuropatologías asociadas al envejecimiento cerebral. Reivindicacion 1: Compuesto formula (1) en la cual n representa un entero de 1 a 6, inclusive, R1 y R2, que pueden ser idénticos o diferentes, representan, independientemente entre sí, un átomo de H, alquilo C1-6 lineal o ramificado o arilalquilo C1-6, en el cual la parte alquilo puede ser lineal o ramificada; R3 y R4, que pueden ser idénticos o diferentes, representan, cada uno independientemente del otro, H o alquilo C1-6 lineal o ramificado; R5 y R6, que pueden ser idénticos o diferentes, representan, cada uno independientemente del otro, H o alquilo C1-6 lineal o ramificado, halogeno, hidroxi, alcoxi C1-6 lineal o ramificado, ciano, nitro, acilo C2-6 lineal o ramificado, alcoxicarbonilo C1-6 lineal o ramificado, trihaloalquilo C1-6 lineal o ramificado, o trihaloalcoxi C1-6 lineal o ramificado, o un grupo amino, opcionalmente sustituido por 1 o 2 grupos alquilo C1-6 lineal o ramificado; R7 representa H, alquilo C1-6 lineal o ramificado, o un grupo arilalquilo C1-6 en el cual la parte alquilo puede ser lineal o ramificada, se entiende por grupo arilo, un grupo fenilo, bifenilo, naftilo, dihidronaftilo, tetrahidronaftilo, indanilo o indenilo, y cada uno de esos grupos puede ser sustituido, opcionalmente, por uno o más grupos idénticos o diferentes, seleccionados entre átomos de halogeno, alquilo C1-6 lineal o ramificado, hidroxi, ciano, nitro, alcoxi C1-6 lineal o ramificado, acilo C2-7 lineal o ramificado, alcoxicarbonilo C1-6 lineal o ramificado, trihaloalquilo C1-6 lineal o ramificado, trihaloalcoxi C1-6 lineal o ramificado, y grupos amino, sustituidos, opcionalmente, por 1 o 2 grupos alquilo C1-6 lineal o ramificado.
-
公开(公告)号:AU2007209235A1
公开(公告)日:2007-08-02
申请号:AU2007209235
申请日:2007-01-30
Applicant: SERVIER LAB
Inventor: CHARTON YVES , LOCKHART BRIAN , GOLDSTEIN SOLO , GUILLONNEAU CLAUDE , LESTAGE PIERRE
IPC: C07D213/65 , A61K31/4418 , A61P25/00 , C07D401/10
Abstract: Compounds of formula (I): wherein: n represents an integer of from 1 to 6 inclusive, X represents an oxygen atom or an NR6 group, Y represents a carbon atom or a nitrogen atom, Z represents a carbon atom or a nitrogen atom, R1 and R2 represent a hydrogen atom or an alkyl or arylalkyl group, R3 and R4 represent a hydrogen atom or an alkyl group, R5 represents a hydrogen atom or an alkyl, halogen, hydroxy, alkoxy, cyano, nitro, acyl, alkoxycarbonyl, trihaloalkyl, trihaloalkoxy or optionally substituted amino group, R6 represents a hydrogen atom or an alkyl or arylalkyl group, Ra, Rb, Rc, Rd and Re are as defined in the description. Medicinal products containing the same which are useful as specific nicotinic ligands of α4&bgr;2 receptors.
-
公开(公告)号:AT366245T
公开(公告)日:2007-07-15
申请号:AT02805407
申请日:2002-12-20
Applicant: SERVIER LAB
Inventor: CORDI ALEX , DESOS PATRICE , LESTAGE PIERRE
IPC: C07D279/02 , A61K31/5415 , A61K31/549 , A61P9/10 , A61P25/08 , A61P25/14 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07B61/00 , C07D285/24
Abstract: Benzothia(dia)zine derivatives (I), their isomers and salts are new. Benzothia(dia)zine derivatives (I), their isomers and salts are new; R1 = OH or RCOO-; R2 = H, halogen, OH or R'COO-; R, R' = 1-6C alkyl or 2-6C alkenyl (both optionally substituted by aryl), 1-6C perhaloalkyl, 3-7C cycloalkyl, adamantyl, aryl, or heteroaryl; R3 = H, 1-6C alkyl, or 3-7C cycloalkyl; A = CR4R5 or NR4; R4 = H or 1-6C alkyl; R5 = H or halogen Provided that: (1) when R1 is RCOO- it is in position 5; (2) aryl groups are mono or bicyclic and may be substituted by alkyl, alkoxy, perhaloalkyl, perhaloalkoxy, OH, CN, alkyl, mono- or dialkylamino, aminosulfonyl, mono or dialkylaminosulfonyl, or optionally substituted phenyl; and (3) heteroaryl groups may have up to three heteroatoms (O, N, S), may be mono or bicyclic and may be substituted as described for aryl groups. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:DE602004002990T2
公开(公告)日:2007-07-05
申请号:DE602004002990
申请日:2004-06-09
Applicant: SERVIER LAB
Inventor: DESOS PATRICE , CORDI ALEX , LESTAGE PIERRE
IPC: C07D513/04 , A61K31/54 , A61K31/549 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D513/02
Abstract: Benzothiazine or benzothiadiazine derivatives (I) are new. Benzothiazine or benzothiadiazine derivatives of formula (I) and their isomers and salts are new: [Image] R 1H, halo or 1-6C alkyl; R 1a = H or 1-6C alkyl; R 2H, halo or OH; A : NR 4or CR 4R 5; R 3H, 1-6C alkyl or 3-7C cycloalkyl; R 4H or 1-6C alkyl; R 5H or halo; R 6R 4or forms a CH 2(CH 2) mCH 2group with R 3; m : 1-3; X : NR 6R 7, SO nR 8, OR' 8or a heterocyclic group; R 6, R 7H or 1-6C alkyl, or R 6is SO pR 9, COR 9or P(O)(OR 9)(OR 10); or NR 6R 7is a heterocyclic group; R 8-R 10H, 1-6C (halo)alkyl, aralkyl or aryl; R' 81-6C alkyl or 1-6C acyl; n, p : 1 or 2. [Image] An independent claim is also included for two processes for preparing (I). ACTIVITY : Nootropic. MECHANISM OF ACTION : alpha -Amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) modulator. (3-(5,5-Dioxido-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazin-7-yloxy)phenyl)methanamine hydrochloride increased the current intensity induced by AMPA in Xenopusoocytes by a factor of 2 at 3.5 MicroM and by a factor of 5 at 9.2 MicroM.
-
公开(公告)号:FR2885615B1
公开(公告)日:2007-06-22
申请号:FR0504757
申请日:2005-05-12
Applicant: SERVIER LAB
Inventor: DESOS PATRICE , CORDI ALEXIS , LESTAGE PIERRE
IPC: C07D413/14 , A61K31/496 , A61P3/04 , A61P25/00 , A61P29/00 , C07D213/74 , C07D241/04 , C07D295/26 , C07D401/04
Abstract: Phenyl pyridinyl piperazine derivatives (I), their enantiomers and diastereoisomers, acid and base addition salts are new. Phenyl pyridinyl piperazine derivatives of formula (I), their enantiomers and diastereoisomers, acid and base addition salts are new. R 1NR 3SO 2R 4; R 3H or 1-6C alkyl; R 41-6C alkyl, T or NR 5R 6; either R 5, R 6R 3, 3-8C cycloalkyl or 3-8C cycloalkyl-1-6C alkyl; NR 5R 65-8 membered ring (where C is optionally replaced by S, N, O, SO or SO 2) (optionally bridged by a 1-6C alkyl and/or optionally to be substituted by T 1); T 1halo, 1-6C (polyhalo)alkyl, 1-6C alkoxy, COOH, OH, CN, NO 2, NH 2 (optionally substituted by 1-6C alkyl); R 21-6C alkyl, 3-8C cycloalkyl, 3-8C cycloalkyl-1-6C alkyl; and T : aryl e.g. phenyl, naphtyl or biphenyl (all optionally substituted by T 1). An independent claim is included for the preparation of (I). [Image] ACTIVITY : Nootropic; Neuroprotective; Cerebroprotective; Anticonvulsant; Tranquilizer; Anorectic; Analgesic; CNS-Gen.; Antiparkinsonian. MECHANISM OF ACTION : Central histaminergic H3 receptor antagonist. The antagonistic activity of (I) against central histaminergic H3 receptor antagonist was tested. The results showed that (I) exhibited a significant antagonistic activity against central histaminergic H3 receptor antagonist.
-
公开(公告)号:NZ547121A
公开(公告)日:2007-05-31
申请号:NZ54712106
申请日:2006-05-11
Applicant: SERVIER LAB
Inventor: DESOS PATRICE , CORDI ALEXIS , LESTAGE PIERRE
IPC: C07D401/04 , C07D401/14 , A61K31/496 , A61K31/44 , A61P25/00
Abstract: Disclosed are compounds of formula (I) wherein: R1 represents and NR3SO2R4 group; R3 represents an H atom or a linear or branched alkyl group; R4 represents a linear or branched alkyl group, an aryl group or an NR5R6group where R5 and R6 are as defined; and R2 represents a linear or branched alkyl group, cycloalkyl group or a cycloalkyl-alkyl group wherein the alkyl moiety may be linear or branched. Compounds of the type disclosed specifically interact with H3 histamine receptors and can be used in the treatment of neuropathologies associated with cerebral ageing, mood disorders, eating behaviour, sleep-wakefulness rhythm and of attention deficit hyperactivity syndrome.
-
-
-
-
-
-
-
-
-